🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Chemotherapy given together is a standard way to treat your cancer. One sta...
Status
Completed
Location
City of Hope Cancer Center
Start Date
2006-10-23
Trial ID
NCT00515411
The purpose of the study is to compare disease-free survival (DFS) of women...
Status
Completed
Location
Helsinki University Central Hospital, Department of Oncology
Start Date
2008-01
Trial ID
NCT00593697
The purpose of this study will be to evaluate the safety, tolerability, and...
Status
Terminated
Location
University of Alabama At Birmingham Comprehensive Cancer Center
Start Date
2015-02-27
Trial ID
NCT02393248
Treatments Being Tested
This phase II trial studies how well trastuzumab and pertuzumab or bevacizu...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2013-09-24
Trial ID
NCT01959490
Treatments Being Tested
This is a global Phase III, two-arm, open-label, multicenter, randomized st...
Status
Completed
Location
Maryland Oncology Hematology
Start Date
2018-06-14
Trial ID
NCT03493854
The purpose of this study is to test the safety and effectiveness of a sequ...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2024-08-08
Trial ID
NCT06439693
Among women with stage I HER2-positive breast cancer, adjuvant weekly pacli...
Status
Unknown
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2022-01-31
Trial ID
NCT05189067
Treatments Being Tested
This is a prospective, Phase IV, multi-center, single arm, open-label, inte...
Status
Completed
Location
Yashoda Hospital
Start Date
2015-08-18
Trial ID
NCT02419742
Treatments Being Tested
In the TROIKA study, the proposed biosimilar HD201 will be compared to its ...
Status
Completed
Location
Minsk Clinical Oncological Dispensary
Start Date
2018-02-19
Trial ID
NCT03013504
Treatments Being Tested
It is a multicenter, open-label, two stage phase II trial, to assess activi...
Status
Completed
Location
IRST Oncologia medica
Start Date
2014-12-17
Trial ID
NCT02488564
Treatments Being Tested